Reeve Emma
SEC-identified person · CIK 1680329 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Zeta Acquisition Corp II WHWK | Director | filed 2021 - 2026 |
| PTC Therapeutics, INC. PTCT | Director | filed 2018 - 2026 |
| Editas Medicine, Inc. EDIT | Director | filed 2021 - 2024 |
| Constellation Pharmaceuticals INC CNST | Chief Financial Officer | filed 2018 - 2021 |
| Parexel International Corp PRXL | Corp. VP & Interim CFO | filed 2016 - 2016 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.